Cargando…

Anti-SARS drug screening by molecular docking

Starting from a collection of 1386 druggable compounds obtained from the 3D pharmacophore search, we performed a similarity search to narrow down the scope of docking studies. The template molecule is KZ7088 (Chou et al., 2003, Biochem Biophys Res Commun 308: 148–151). The MDL MACCS keys were used t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, D.-Q., Zhang, R., Du, Q.-S., Gao, W.-N., Li, Y., Gao, H., Wang, S.-Q., Zhang, X., Li, A.-X., Sirois, S., Chou, K.-C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087968/
https://www.ncbi.nlm.nih.gov/pubmed/16715412
http://dx.doi.org/10.1007/s00726-006-0361-7
_version_ 1783509443290333184
author Wei, D.-Q.
Zhang, R.
Du, Q.-S.
Gao, W.-N.
Li, Y.
Gao, H.
Wang, S.-Q.
Zhang, X.
Li, A.-X.
Sirois, S.
Chou, K.-C.
author_facet Wei, D.-Q.
Zhang, R.
Du, Q.-S.
Gao, W.-N.
Li, Y.
Gao, H.
Wang, S.-Q.
Zhang, X.
Li, A.-X.
Sirois, S.
Chou, K.-C.
author_sort Wei, D.-Q.
collection PubMed
description Starting from a collection of 1386 druggable compounds obtained from the 3D pharmacophore search, we performed a similarity search to narrow down the scope of docking studies. The template molecule is KZ7088 (Chou et al., 2003, Biochem Biophys Res Commun 308: 148–151). The MDL MACCS keys were used to fingerprint the molecules. The Tanimoto coefficient is taken as the metric to compare fingerprints. If the similarity threshold was 0.8, a set of 50 unique hits and 103 conformers were retrieved as a result of similarity search. The AutoDock 3.011 was used to carry out molecular docking of 50 ligands to their macromolecular protein receptors. Three compounds, i.e., C(28)H(34)O(4)N(7)Cl, C(21)H(36)O(5)N(6), and C(21)H(36)O(5)N(6), were found that may be promising candidates for further investigation. The main feature shared by these three potential inhibitors as well as the information of the involved side chains of SARS Cov Mpro may provide useful insights for the development of potent inhibitors against SARS enzyme.
format Online
Article
Text
id pubmed-7087968
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-70879682020-03-23 Anti-SARS drug screening by molecular docking Wei, D.-Q. Zhang, R. Du, Q.-S. Gao, W.-N. Li, Y. Gao, H. Wang, S.-Q. Zhang, X. Li, A.-X. Sirois, S. Chou, K.-C. Amino Acids Article Starting from a collection of 1386 druggable compounds obtained from the 3D pharmacophore search, we performed a similarity search to narrow down the scope of docking studies. The template molecule is KZ7088 (Chou et al., 2003, Biochem Biophys Res Commun 308: 148–151). The MDL MACCS keys were used to fingerprint the molecules. The Tanimoto coefficient is taken as the metric to compare fingerprints. If the similarity threshold was 0.8, a set of 50 unique hits and 103 conformers were retrieved as a result of similarity search. The AutoDock 3.011 was used to carry out molecular docking of 50 ligands to their macromolecular protein receptors. Three compounds, i.e., C(28)H(34)O(4)N(7)Cl, C(21)H(36)O(5)N(6), and C(21)H(36)O(5)N(6), were found that may be promising candidates for further investigation. The main feature shared by these three potential inhibitors as well as the information of the involved side chains of SARS Cov Mpro may provide useful insights for the development of potent inhibitors against SARS enzyme. Springer-Verlag 2006-05-22 2006 /pmc/articles/PMC7087968/ /pubmed/16715412 http://dx.doi.org/10.1007/s00726-006-0361-7 Text en © Springer-Verlag 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Wei, D.-Q.
Zhang, R.
Du, Q.-S.
Gao, W.-N.
Li, Y.
Gao, H.
Wang, S.-Q.
Zhang, X.
Li, A.-X.
Sirois, S.
Chou, K.-C.
Anti-SARS drug screening by molecular docking
title Anti-SARS drug screening by molecular docking
title_full Anti-SARS drug screening by molecular docking
title_fullStr Anti-SARS drug screening by molecular docking
title_full_unstemmed Anti-SARS drug screening by molecular docking
title_short Anti-SARS drug screening by molecular docking
title_sort anti-sars drug screening by molecular docking
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087968/
https://www.ncbi.nlm.nih.gov/pubmed/16715412
http://dx.doi.org/10.1007/s00726-006-0361-7
work_keys_str_mv AT weidq antisarsdrugscreeningbymoleculardocking
AT zhangr antisarsdrugscreeningbymoleculardocking
AT duqs antisarsdrugscreeningbymoleculardocking
AT gaown antisarsdrugscreeningbymoleculardocking
AT liy antisarsdrugscreeningbymoleculardocking
AT gaoh antisarsdrugscreeningbymoleculardocking
AT wangsq antisarsdrugscreeningbymoleculardocking
AT zhangx antisarsdrugscreeningbymoleculardocking
AT liax antisarsdrugscreeningbymoleculardocking
AT siroiss antisarsdrugscreeningbymoleculardocking
AT choukc antisarsdrugscreeningbymoleculardocking